People

Yeongmok Gil

Yeongmok Gil (길영목) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Yeongmok has built an unconventional career spanning equity research, fund management, consulting, and investor relations and disclosure at listed companies. This breadth of experience gives him a differentiated perspective on both identifying investment opportunities and structuring exits. He has led investments across biotechnology, secondary transactions, and mezzanine deals involving listed companies. He primarily invests from Series B onward and takes a sector-agnostic approach. Guided by the belief that great companies are built by great management teams, he places particular emphasis on the quality of management and the soundness of their decision-making. He also identifies more closely with Charlie Munger’s philosophy of sharp, disciplined thinking behind the scenes than with Warren Buffett’s more publicly visible optimism, and brings that perspective into his investment decisions. Published education: B.S., Biochemical Engineering, KyungHee University. The primary profile’s career/background list names FnGuide, Herb Doctor International, Bio Partners, Prodizen, CKD Venture Investment; undated entries are not independently verified concurrent appointments. Published areas: Bio, Consumer, Secondary. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.